Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
9.65%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Processa Pharmaceuticals, Inc.
Market Cap
$4.21M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.32M
Gross Margin
31.52%
TTM Avg
25.06%
3Y Avg
26.02%
5Y Avg
31.75%
Market Cap
$4.40M
Gross Margin
26.32%
TTM Avg
-195.38%
3Y Avg
-178.16%
5Y Avg
-96.97%
Market Cap
$3.93M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
-19.05%
Market Cap
$3.90M
Gross Margin
19.42%
TTM Avg
29.47%
3Y Avg
-30.48%
5Y Avg
-4.58%
Market Cap
$4.53M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.55M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | $4.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | 0.00% | 0.00% | 0.00% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | 31.52% | 25.06% | 26.02% | 31.75% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | 26.32% | -195.38% | -178.16% | -96.97% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | 0.00% | 0.00% | 25.00% | -19.05% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | 19.42% | 29.47% | -30.48% | -4.58% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| CalciMedica, Inc. (CALC)vs › | $4.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Imunon, Inc. (IMNN)vs › | $4.71M | 0.00% | 0.00% | 25.00% | 50.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 100.00% |
| 2015-12-31 | 578.03% |
| 2015-09-30 | 26.73% |
| 2015-06-30 | 45.07% |
| 2015-03-31 | 37.18% |
| 2014-12-31 | 40.07% |
| 2014-09-30 | 51.94% |
| 2014-06-30 | 37.79% |
| 2014-03-31 | 55.07% |
| 2013-12-31 | 51.63% |
| 2013-09-30 | 36.11% |
| 2013-06-30 | 36.75% |
| 2013-03-31 | 36.85% |
| 2012-12-31 | -5.26% |
| 2012-09-30 | 30.87% |
| 2012-06-30 | 44.52% |
| 2012-03-31 | 15.12% |
| 2011-12-31 | 100.00% |
